Inovio Pharmaceuticals Inc (INO.A)
INO.A on American Stock Exchange
0.89USD
1 Jul 2013
0.89USD
1 Jul 2013
Price Change (% chg)
$0.09 (+11.80%)
$0.09 (+11.80%)
Prev Close
$0.80
$0.80
Open
$0.82
$0.82
Day's High
$1.00
$1.00
Day's Low
$0.82
$0.82
Volume
614,692
614,692
Avg. Vol
153,343
153,343
52-wk High
$1.00
$1.00
52-wk Low
$0.44
$0.44
About
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such... (more)
Overall
| Beta: | 3.10 |
| Market Cap (Mil.): | $143.25 |
| Shares Outstanding (Mil.): | 179.94 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| INO.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 34.05 | 33.02 |
| EPS (TTM): | -0.14 | -- | -- |
| ROI: | -48.62 | -2.50 | 19.07 |
| ROE: | -50.88 | -3.10 | 20.00 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $27.78 | -0.23 |
| Novartis AG (NOVN.VX) | CHF67.30 | +0.20 |
| Merck & Co., Inc. (MRK.N) | $46.32 | -0.13 |
| Roche Holding Ltd. (ROG.VX) | CHF234.60 | -0.40 |
| Sanofi SA (SASY.PA) | €79.87 | +0.25 |
| AstraZeneca plc (AZN.L) | 3,151.00p | +36.00 |
| GlaxoSmithKline plc (GSK.L) | 1,658.50p | +10.50 |
| Crucell N.V. (CRCL.AS) | -- | -- |
| Transgene SA (TRNG.PA) | €9.09 | -0.02 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

